{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:04:13Z","timestamp":1759104253879,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","award":["H29-iyaku-ippan-002"],"award-info":[{"award-number":["H29-iyaku-ippan-002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jviromet.2021.114244","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T02:02:27Z","timestamp":1626919347000},"page":"114244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Phenotypic characterization of cell culture-derived hepatitis E virus subjected to different chemical treatments: Application in virus removal via nanofiltration"],"prefix":"10.1016","volume":"296","author":[{"given":"Shoji","family":"Ideno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadue","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Urayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Maeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2021.114244_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/vox.12156","article-title":"Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma","volume":"107","author":"Andonov","year":"2014","journal-title":"Vox Sang."},{"key":"10.1016\/j.jviromet.2021.114244_bib0010","series-title":"Annals of Blood 1","article-title":"An overview of plasma fractionation","author":"Burnouf","year":"2018"},{"key":"10.1016\/j.jviromet.2021.114244_bib0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biochi.2017.05.003","article-title":"Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response","volume":"141","author":"Chapuy-Regaud","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.jviromet.2021.114244_bib0020","doi-asserted-by":"crossref","DOI":"10.1021\/ja01207a034","article-title":"Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids","volume":"68","author":"Cohn","year":"1946","journal-title":"J. Am. Chem. Soc."},{"year":"1996","series-title":"Virus Validation Studies: the Design, Contribution and Interpretation of Studies Validating the Inactivation and Removal of Viruses","author":"EMA","key":"10.1016\/j.jviromet.2021.114244_bib0025"},{"year":"2014","series-title":"Concept Paper on Viral Safety of Plasma-derived Medicinal Products with Respect to Hepatitis E Virus (EMA\/CHMP\/BWP\/78086\/2014)","author":"EMA","key":"10.1016\/j.jviromet.2021.114244_bib0030"},{"key":"10.1016\/j.jviromet.2021.114244_bib0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/trf.13343","article-title":"Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes","volume":"56","author":"Farcet","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.jviromet.2021.114244_bib0040","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3201\/eid2612.191482","article-title":"Risk for hepatitis e virus transmission by solvent\/detergent-treated plasma","volume":"26","author":"Gallian","year":"2020","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.jviromet.2021.114244_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2019.113755","article-title":"Quantitative PCR evaluation of parvovirus B19 removal via nanofiltration","volume":"275","author":"Ideno","year":"2020","journal-title":"J. Virol. Methods"},{"year":"1999","series-title":"Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin","author":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use (ICH)","key":"10.1016\/j.jviromet.2021.114244_bib0050"},{"key":"10.1016\/j.jviromet.2021.114244_bib0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jviromet.2005.07.004","article-title":"A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus","volume":"131","author":"Jothikumar","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2021.114244_bib0060","doi-asserted-by":"crossref","first-page":"17086","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis e virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat. Rev. Dis. primers"},{"key":"10.1016\/j.jviromet.2021.114244_bib0065","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/trf.14091","article-title":"A nonenveloped virus with a lipid envelope: hepatitis A virus as used in virus-reduction studies","volume":"57","author":"Kapsch","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.jviromet.2021.114244_bib0070","doi-asserted-by":"crossref","DOI":"10.1111\/trf.16014","article-title":"Antibody-enhanced hepatitis E virus nanofiltration during the manufacture of human immunoglobulin","author":"Kapsch","year":"2020","journal-title":"Transfusion."},{"key":"10.1016\/j.jviromet.2021.114244_bib0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven behandlung pharmakologischer reihenversuche naunyn schmiedebergs","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Arch. Exp. Pathol. Pharmakol."},{"key":"10.1016\/j.jviromet.2021.114244_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/v8080212","article-title":"Hepatitis e pathogenesis","volume":"8","author":"Lhomme","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2021.114244_bib0085","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/vox.12425","article-title":"Hepatitis E virus in donor plasma collected in Japan","volume":"111","author":"Minagi","year":"2016","journal-title":"Vox Sang."},{"key":"10.1016\/j.jviromet.2021.114244_bib0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1423-0410.2010.01445.x","article-title":"Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates","volume":"100","author":"Modrow","year":"2011","journal-title":"Vox Sang."},{"key":"10.1016\/j.jviromet.2021.114244_bib0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.gastro.2017.09.020","article-title":"Hepatitis e virus lifecycle and identification of 3 forms of the ORF2 capsid protein","volume":"154","author":"Montpellier","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2021.114244_bib0100","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1099\/vir.0.066910-0","article-title":"Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies","volume":"95","author":"Nagashima","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2021.114244_bib0105","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00705-013-1912-3","article-title":"The membrane on the surface of hepatitis E virus particles is derived from the intracellular membrane and contains trans-Golgi network protein 2","volume":"159","author":"Nagashima","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jviromet.2021.114244_bib0110","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00822-17","article-title":"Characterization of the quasi-enveloped hepatitis e virus particles released by the cellular exosomal pathway","volume":"91","author":"Nagashima","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2021.114244_bib0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrgastro.2017.150","article-title":"Hepatitis E virus: advances and challenges","volume":"15","author":"Nimgaonkar","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jviromet.2021.114244_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051294","article-title":"On the host side of the hepatitis e virus life cycle","volume":"9","author":"Oechslin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jviromet.2021.114244_bib0125","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1111\/trf.16022","article-title":"Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years\u2019 experience of the plasma protein manufacturers","volume":"60","author":"Roth","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.jviromet.2021.114244_bib0130","doi-asserted-by":"crossref","DOI":"10.3390\/v11060483","article-title":"Isolation of subtype 3c, 3e and 3f-Like hepatitis e virus strains stably replicating to high viral loads in an optimized cell culture system","volume":"11","author":"Schemmerer","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2021.114244_bib0135","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1128\/JCM.02002-09","article-title":"Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation","volume":"48","author":"Takahashi","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114244_bib0140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/trf.13976","article-title":"Hepatitis E risks: pigs or blood-that is the question","volume":"57","author":"Tedder","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.jviromet.2021.114244_bib0145","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1099\/vir.0.010561-0","article-title":"ORF3 protein of hepatitis E virus is essential for virion release from infected cells","volume":"90","author":"Yamada","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2021.114244_bib0150","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1099\/vir.0.007559-0","article-title":"Construction of an infectious cDNA clone of hepatitis E virus strain JE03-1760F that can propagate efficiently in cultured cells","volume":"90","author":"Yamada","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2021.114244_bib0155","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.02804-15","article-title":"Distinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis e viruses","volume":"90","author":"Yin","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2021.114244_bib0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1423-0410.2008.01078.x","article-title":"Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters","volume":"95","author":"Yunoki","year":"2008","journal-title":"Vox Sang."},{"key":"10.1016\/j.jviromet.2021.114244_bib0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.biologicals.2016.05.004","article-title":"Hepatitis E virus derived from different sources exhibits different behaviour in virus inactivation and\/or removal studies with plasma derivatives","volume":"44","author":"Yunoki","year":"2016","journal-title":"Biol.: J. Int. Assoc. Biol. Stand."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609342100183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609342100183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:54:31Z","timestamp":1759056871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016609342100183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":33,"alternative-id":["S016609342100183X"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114244","relation":{},"ISSN":["0166-0934"],"issn-type":[{"type":"print","value":"0166-0934"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic characterization of cell culture-derived hepatitis E virus subjected to different chemical treatments: Application in virus removal via nanofiltration","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114244"}}